Search Results - "Tesic, Danka"
-
1
Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review
Published in Expert review of pharmacoeconomics & outcomes research (01-10-2018)“…Evolocumab is fully human monoclonal antibody which binds to proprotein convertase subtilisin/kexin type 9 (PCSK9), and prevents its blocking effect on…”
Get more information
Journal Article -
2
Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on data a Balkan country in socioeconomic transition
Published in Vojnosanitetski pregled (01-07-2009)“…A cost-effectiveness analyses of immunomodulatory treatments for relapsing-remitting multiple sclerosis (RRMS) in developed countries have shown that any…”
Get full text
Journal Article -
3
Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia
Published in Kardiologia polska (01-01-2015)“…Recent studies have shown that dronedarone is associated with significantly fewer adverse effects and treatment discontinuations, and a trend toward reduced…”
Get full text
Journal Article -
4
Addressing challenges for sustainable healthcare in Central and Eastern Europe
Published in Expert review of pharmacoeconomics & outcomes research (01-12-2016)“…All European countries face increasing challenges in the provision of equitable and comprehensive healthcare for their citizens in view of a number of factors…”
Get more information
Journal Article -
5
Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis
Published in Journal of nephrology (01-07-2009)“…Both use of nonsteroidal antiinflammatory drugs (NSAIDs) and chronic renal insufficiency are significant independent risk factors for gastrointestinal…”
Get more information
Journal Article -
6
The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia
Published in Expert review of pharmacoeconomics & outcomes research (01-01-2017)“…The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in…”
Get more information
Journal Article -
7
Cost-effectiveness of four immunomodulatory therapies for relapsingremitting multiple sclerosis: A Markov model based on data a Balkan country in socioeconomic transition
Published in Vojnosanitetski pregled (2009)“…Background/Aim. A cost-effectiveness analyses of immunomodulatory treatments for relapsing-remitting multiple sclerosis (RRMS) in developed countries have…”
Get full text
Journal Article